Kumamoto University scientists have unveiled a novel compound, HPH-15, with dual effects of reducing blood glucose levels and combating fat accumulation, marking a significant leap in diabetes treatment innovation.
Extraordinary general meeting approves sale of Carragelose division – Biotech Investments
EQS-News: Marinomed Biotech AG / Key word(s): Strategic Company Decision/AGM/EGM Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division 19.12.2024 / 12:39 CET/CEST